Rimonabant is a popular prescription weight loss drug that is currently available in 18 countries (under the name Acomplia - from Sanofi-Aventis). The drug has been before the FDA - awaiting approval for some time now.
Some time last year I wrote a large article that discussed some of the side effects of the drug.
The FDA has now released an analysis - showing why they are taking such a long time to look at Zimulti (Rimonabant).
Leave a Reply
*
To prove that you're not a bot, enter this code
